Nuvectis Pharma, Inc.
NVCT
$11.04
-$1.41-11.33%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -15.85% | 70.69% | 106.43% | 47.90% | 53.43% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -5.63% | 1.35% | 5.07% | 17.58% | 13.60% |
| Total Current Assets | -15.76% | 70.41% | 105.62% | 47.60% | 52.93% |
|
|
|||||
| Total Current Assets | -15.76% | 70.41% | 105.62% | 47.60% | 52.93% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -15.76% | 70.41% | 105.62% | 47.60% | 52.93% |
|
|
|||||
| Total Accounts Payable | 56.92% | 151.16% | 184.79% | 169.61% | 70.10% |
| Total Accrued Expenses | 9.84% | 9.79% | 24.86% | 29.54% | 50.06% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 21.58% | 49.49% | 83.30% | 75.65% | 61.52% |
|
|
|||||
| Total Current Liabilities | 21.58% | 49.49% | 83.30% | 75.65% | 61.52% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 21.58% | 49.49% | 83.30% | 75.65% | 61.52% |
|
|
|||||
| Common Stock & APIC | 20.52% | 42.36% | 49.23% | 35.04% | 37.40% |
| Retained Earnings | -34.56% | -36.10% | -37.88% | -35.11% | -34.51% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -32.14% | 89.57% | 118.45% | 34.67% | 49.44% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -32.14% | 89.57% | 118.45% | 34.67% | 49.44% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -32.14% | 89.57% | 118.45% | 34.67% | 49.44% |
|
|
|||||